Pharma Focus Asia

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility


Lonza opens the world’s largest dedicated cell-and-gene-therapy facility in Pearland, Greater Houston, TX (USA).


The facility was built in anticipation of the rising demand from developers of cell and gene therapies and with the mission of enabling them to deliver these types of treatments to patients around the world more quickly and efficiently.

The 300, 000 square foot (27, 870 square meters) facility and state-of-the-art, fully integrated and world’s most innovative cell-and-gene-therapy manufacturing technologies are unveiled.

The facility with state-of-the-art manufacturing facilities will provide treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.

Nearly 200 full-time staff/high-value positions including scientists, engineers, MBAs and biotechnology professionals are to be recruited as market demand increases.

The site will meet the demands of the growing cell-and-gene-therapy field.


LocationPearland, Greater Houston, TX (USA)
Parties InvolvedLonza
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?